Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Rogers Corp
ROG
$2.18B
| $16.8M | 0.01% |
141,058
+137,560
| +3,933% | +$21.4M |
|
602
Pinduoduo
PDD
$124B
| $16.7M | 0.01% |
+205,227
| New | +$14.3M |
|
603
CarParts.com
PRTS
$42.4M
| $16.7M | 0.01% |
266,560
-214,469
| -45% | -$11.2M |
|
604
Sonoco
SON
$5.62B
| $16.7M | 0.01% |
274,685
+241,191
| +720% | +$14.5M |
|
605
Clorox
CLX
$11.7B
| $16.7M | 0.01% |
118,834
+16,100
| +16% | +$2.29M |
|
606
Alamos Gold
AGI
$11.9B
| $16.6M | 0.01% |
1,641,923
-907,661
| -36% | -$7.99M |
|
|
MODV
607
DELISTED
ModivCare
MODV
| $16.4M | 0.01% |
182,469
-498,833
| -73% | -$44.5M |
|
608
BioAtla
BCAB
$5.61M
| $16.4M | 0.01% |
39,657
-47,332
| -54% | -$19.6M |
|
609
Church & Dwight Co
CHD
$23.1B
| $15.9M | 0.01% |
197,110
-64,788
| -25% | -$4.97M |
|
|
ONT
610
Onterris Inc
ONT
$731M
| $15.9M | 0.01% |
357,426
-357,426
| -50% | -$15.1M |
|
611
Southern Company
SO
$106B
| $15.9M | 0.01% |
222,002
-188,152
| -46% | -$12.6M |
|
612
Vivid Seats
SEAT
$83.2M
| $15.9M | 0.01% |
108,572
-75,032
| -41% | -$11.7M |
|
|
CVII
613
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
| $15.8M | 0.01% |
1,582,884
-748,886
| -32% | -$7.44M |
|
614
Lowe's Companies
LOW
$118B
| $15.7M | 0.01% |
78,771
-85,657
| -52% | -$17.1M |
|
615
Artisan Partners
APAM
$2.82B
| $15.7M | 0.01% |
527,862
-303,646
| -37% | -$9.33M |
|
616
Atlanta Braves Holdings Series B
BATRK
$3.26B
| $15.7M | 0.01% |
486,007
+478,542
| +6,410% | +$14.9M |
|
|
IMGN
617
DELISTED
Immunogen Inc
IMGN
| $15.6M | 0.01% |
3,147,576
+526,592
| +20% | +$2.86M |
|
|
B
618
Barrick Mining
B
$63.2B
| $15.4M | 0.01% |
900,108
-863,278
| -49% | -$13.7M |
|
|
CCRD
619
DELISTED
CoreCard
CCRD
| $15.3M | 0.01% |
528,010
-528,010
| -50% | -$13.8M |
|
|
ITCI
620
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $15.2M | 0.01% |
286,689
-166,793
| -37% | -$8.36M |
|
621
Electronic Arts
EA
$52.9B
| $15.1M | 0.01% |
123,860
+54,628
| +79% | +$6.86M |
|
622
Markel Group
MKL
$23.6B
| $15.1M | 0.01% |
11,493
+10,041
| +692% | +$12.4M |
|
623
Century Casinos
CNTY
$33.2M
| $15.1M | 0.01% |
2,148,279
-2,159,533
| -50% | -$15.8M |
|
624
Xometry
XMTR
$4.69B
| $15.1M | 0.01% |
468,462
-468,460
| -50% | -$21.9M |
|
|
SLGC
625
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $15M | 0.01% |
5,995,631
-6,708,641
| -53% | -$18.7M |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.